1425PABCB1 genetic polymorphism and pharmacokinetic analysis of low dose erlotinib in frail patients with EGFR mutation (mt)-positive, non-small cell lung cancer: TORG1425. (23rd October 2018) - Miyamoto, S; Tokkito, T; Bessho, A; Fukamatsu, N; Kunitoh, H; Ishii, M; Tanaka, H; Aono, H; Fukui, T; Kusaka, K; Hosomi, Y; Hamada, A; et al.